CNTMF Cansortium Inc.

Cansortium, Inc. engages in the production and sale of medical cannabis. It focuses on oil extracted and derived products for use by medical patients. Its objective is to invest in and develop multiple jurisdictions for the vertical integrated approach for the sale, and distribution of processed cannabis oil in medical use frameworks. The company was founded by Jose Jaiver Hidalgo and Batievsky Henry on August 31, 2018 and is headquartered in Miami, FL.

This security is traded over-the-counter, or OTC. We don't always have accurate pricing data on OTC stocks.

$0.60    OTCQX
As of 01/26/2022     OTCMarkets

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Consumer Discretionary
Industry:  Drug Manufacturers—Specialty &
Index country:  Canada
Country of incorporation:  
IPO date:  04/16/2019
Outstanding shares:  113,803,920
Average volume:  107,175
Market cap:   $67,144,313
Current dividend yield:  0.00%
Sedol:      

---

Valuation   (See tab for details)

---

PE ratio:   -2.16
PB ratio:   2.03
PS ratio:   1.09
Return on equity:   -43.12%
Net income %:   -50.31%